Mid Cap Archives - Page 123 of 126

2 minute read

How About Receiving Monthly Dividend Payments? 2 REITs And 1 Energy Company To Consider

September 4, 9:43 AM

As high returns are harder to come by today than in the past two years, investing in dividend stocks that pay distributions monthly is a big advantage, as most firms tend to pay dividends quarterly.

AGNC

2 minute read

These 3 S&P 500 Dividend Stocks Have High Compound Annual Growth Rates Through 2024

By Robert Kuczmarski

September 3, 3:11 PM

Based on consensus estimates among surveyed analysts, FactSet has determined which stocks in the S&P 500 that have the highest expected two-year dividend compound annual growth rate.

AMGN

1 minute read

Cramer Chats With Signet Jewelers About $360M Blue Nile Deal, Expanding Market Share

By Robert Kuczmarski

September 2, 5:39 PM

Signet Jewelers Ltd. (NYSE: SIG) CEO Gina Drosos recently appeared on Jim Cramer’s ‘Mad Money’ to discuss the company's recent $360-million acquisition of online jewelry retailer Blue Nile.

SIG

2 minute read

These Stocks Take A Hit As Covid-19 Outbreak Leads To Megacity Lockdown In China

By AJ Fabino

September 2, 12:48 PM

China announced on Thursday that it would declare a state of emergency in Chengdu, a prominent southwestern province.

BYDDY

2 minute read

Two High-Yielding Stocks Famed Gold And Subprime Mortgage Trader John Paulson Owns

By Robert Kuczmarski

September 1, 3:11 PM

John Paulson is a billionaire investor and hedge fund manager of Paulson & Co., which he founded in 1994 as an investment firm in New York. In the second quarter of 2022, Paulson & Co’s holdings decreased to 32 from 40 in the second quarter of 2021.

2 minute read

Psychedelics Funding At Its Best: $1.5M Destined To Psilocin Clinical Trials In Australia

By Lara Goldstein

September 1, 2:20 PM

Psychedelics biopharma company Lobe Sciences Ltd.

ATAI

3 minute read

Nasdaq-listed Bright Minds Closes $4 Million Offering And Begins Dosing In Clinical Trial For Epilepsy

By Lara Goldstein

August 31, 4:51 PM

Biopharma company developing next-generation mental health treatments Bright Minds Biosciences Inc. (NASDAQ: DRUG) has closed its overnight offering for gross proceeds of approximately $4 million.

DRUG

1 minute read

Up In Smoke: Newly Minted Meme Stock Weber Is Getting Torched

By AJ Fabino

August 31, 4:09 PM

Weber Inc. (NASDAQ: WEBR) shares went up in smoke on Wednesday, falling 16.69% at its lows alongside other meme names like Bed Bath & Beyond Inc (NASDAQ: BBBY).

BBBY

2 minute read

Elon Musk Calls On European Energy Leaders For More Oil And Gas — And This Company Stands To Benefit

By AJ Fabino

August 30, 6:53 PM

Tesla Inc (NASDAQ: TSLA) CEO Elon Musk told shareholders on Monday at the 2022 Offshore Northern Shore Conference in Stavanger, Norway, that the world needs more oil and natural gas,

3 minute read

Why Lose Money In A Bear Market? These Stocks Are Bucking The Trend In 2022

By AJ Fabino

August 30, 12:46 PM

Contrary to 2021, when equity markets were in a bull run, 2022 has served as a not-so-gentle reminder that the stock market does not give free gifts. The macro attitude that is pushing the markets lower has been influenced by worries about a recession, geopolitical tensions, the energy crisis, and record inflation.

CDEV